BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 2, 2016
View Archived Issues
Sumitomo Dainippon Pharma recaps clinical developments of first quarter of fiscal 2016
Read More
Ligand Pharmaceuticals licenses three programs from Nucorion Pharmaceuticals
Read More
The Vanderbilt University reports mGlu4 receptor PAMs
Read More
Bayer Healthcare patents chemokine receptor antagonists
Read More
Korea Research Institute of Bioscience and Biotechnology discloses antibiotic compounds
Read More
Janssen Pharmaceutica introduces cannabinoid CB1 inverse agonists
Read More
University of California, Oakland describes heat schock protein inhibitors
Read More
Atovaquone alleviates tumor hypoxia and increases the sensitivity of tumor cells to radiation
Read More
Nusinersen meets primary endpoint at interim analysis of phase III ENDEAR study
Read More
Hetlioz becomes available in Germany
Read More
Biogen initiates phase I trial of BIIB-068 in healthy subjects
Read More
Celgene reflects on key events of second quarter 2016
Read More
Orexigen Therapeutics completes acquisition of U.S. rights to Contrave
Read More
NP-03 shows promise for AD in vivo
Read More
FDA grants breakthrough therapy designation to MEI Pharma's pracinostat
Read More
Tetraphase Pharmaceuticals begins dosing patients in phase I study of TP-6076
Read More
SciFluor Life Sciences to begin clinical testing of SF-0166 for retinal diseases
Read More
Genetic variant in BMAL1 is associated with higher risk of CVD
Read More
Cognitive tests are potentially useful to test new AD therapy efficacy
Read More
Aptevo Therapeutics launches after separation from Emergent BioSolutions
Read More
Heron Therapeutics reports results from two phase II studies of HTX-011
Read More
Phase III ALCANZA trial of Adcetris in CTCL meets primary endpoint
Read More
FDA grants fast track status to Vaccinex's VX-15 for Huntington's disease
Read More
Scynexis' SCY-078 shows favorable safety, tolerability in phase II study in invasive candidiasis
Read More
Ebola vaccine demonstrates complete protection in nonhuman primate challenge models
Read More
EC grants orphan drug designation to C21 for the treatment of IPF
Read More
National Parkinson Foundation and the Parkinson's Disease Foundation complete merger
Read More
InBios receives development support to advance Zika diagnostic
Read More
Pfizer acquires Bamboo Therapeutics and significantly expands its gene therapy expertise
Read More